Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New scan could replace risky biopsy for organ donors

NCT ID NCT07451379

Summary

This study aims to see if a quick, non-invasive scan called FibroScan is as accurate as a standard liver biopsy for measuring fat in a potential donor's liver. Researchers will compare the two methods in 100 adults who are eligible to donate part of their liver. The goal is to find a safer, easier way to screen donors without the risks of a biopsy.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-INVASIVE DONOR LIVER ASSESSMENT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.